Tirzepatide is a new drug targeting glucagon-like peptide 1 (GLP1) and gastric inhibitory
polypeptide (GIP) receptors. This drug has demonstrated great potential in improving the …

It has been four years since long COVID—the protracted consequences that survivors of
COVID-19 face—was first described. Yet, this entity continues to devastate the quality of life …

Sarcopenia is a major health challenge due to an aging population. Probiotics may improve
muscle function through gut-muscle axis, but their efficacy and mechanisms in treating …

This perspective explores the current understanding of the gut microbiota's impact on
cognitive function in apparently healthy humans and in individuals with metabolic disease …

Background Alzheimer's disease (AD) is a neurodegenerative disease characterized by
progressive decline in cognitive function, which significantly increases pain and social …

Population studies provide insights into the interplay between the gut microbiome and
geographical, lifestyle, genetic and environmental factors. However, low-and middle-income …

Both experimental and clinical liver fibrosis leave a metabolic footprint that can be
uncovered and defined using metabolomic approaches. Metabolomics combines pattern …

Sarcopenia refers to an age-related systemic skeletal muscle disorder, which is
characterized by loss of muscle mass and weakening of muscle strength. Gut microbiota can …

The hectic pace of modern life often leads to quick solutions, both in lifestyle and the choice
of food we consume. The importance of the gut microbiome and its balance is being …

Background: A growing body of research supports the role of the microbial communities
residing in the digestive system in the host's cognitive functioning. Most of these studies …